Mylan shareholders approve $35.6B Perrigo purchase

Mylan N.V. announced its shareholders have approved its proposed $35.6 billion takeover of Perrigo Co. PLC.

It plans to launch a formal offer soon. Perrigo, for its part, said that its shareholders would likely reject the unsolicited offer.

A combination of Mylan and Perrigo would create one of the world’s top sellers of low-price medicines with $15.3 billion in yearly sales.

Read more from the Wall Street Journal.